All In Biotech

Drug Trial Radar · NCT02847338

Comparison of Optimal Hypertension Regimens

Comparison of Optimal Hypertension Regimens (Part of the Ancestry Informative Markers in Hypertension (AIMHY) Programme - AIMHY-INFORM)

Last checked: Nov 19, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 940 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

940

Actual

Start

Nov 2016

Primary completion

Oct 2023

Study completion Oct 2023

Sponsor

Lead sponsor
Cambridge University Hospitals NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Medical Research Council
First posted
Jul 28, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

High blood pressure (Hypertension) is extremely common and is a major cause of heart disease, kidney disease and stroke. One in three of the UK (United Kingdom) population will require treatment for hypertension at some point in their lives. A healthy lifestyle alone is often not enough to control blood pressure, and drug treatment is usually required. Although a wide variety of drugs are available to treat hypertension, choosing the right kind of tablet or combination of tablets for individual patients is a problem, and therefore many people have poor blood pressure control. Hypertension treatment within the UK is currently selected according to age and self-defined ethnicity (SDE). There are limitations to this approach which include wide variability in the response to hypertension drug classes between people. There is also uncertainty about selecting hypertension drugs for ethnic minorities other than those of African/Caribbean ancestry, for example, South Asians because of a lack of information from trials. In the AIM HY-INFORM study the investigators are looking to recruit equal number of black/caribbean, south asian and white european participants to be able to compare differences in hypertension treatments and ethnicity. The primary objective of this study is to determine if the response to antihypertensive drugs differs by self defined ethnicity.

Conditions

  • Hypertension

Interventions

  • AmlodipineDrug

    Amlodipine 5mg and Amlodipine 10mg will be one of the treatments in which patients will receive on the monotherapy arm and on the dual therapy arm.

  • LisinoprilDrug

    Lisinopril 10mg and Lisinopril 20mg will be one of the treatments in which patients will receive on the monotherapy arm. Lisinopril 20mg will be one of the treatments in which patients will receive on the dual therapy arm.

  • AmilorideDrug

    Amiloride 10mg will be one of the treatments in which patients will receive on the dual therapy arm.

  • ChlortalidoneDrug

    Chlortalidone 25mg will be one of the treatments in which patients will receive on the dual therapy arm and monotherapy arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Seated Automated Office Systolic Blood PressureTime frame: Approximately 8 weeks after receiving each treatment up to week 24 for mono therapy patients and up to week 32 for dual therapy patients

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Queen Elizabeth Hospital

    Birmingham, United Kingdom

  • Sandwell & West Birmingham Hospitals NHS Trust

    Birmingham, United Kingdom

  • Heartlands Hospital

    Birmingham, United Kingdom

  • University Hospital Llandough

    Cardiff, United Kingdom

  • University of Glasgow

    Glasgow, United Kingdom

  • Liverpool Heart and Chest Hospital

    Liverpool, United Kingdom

  • William Harvey Research Institute, Barts and the London Medical School

    London, United Kingdom

  • St Thomas' Hospital

    London, United Kingdom

  • St George's Hospital

    London, United Kingdom

  • Hammersmith & Fulham GP Partnership: Richford Gate Medical Practice

    London, United Kingdom

  • Manchester Royal Infirmary

    Manchester, United Kingdom

  • Nottingham University Hospital: QMC Campus

    Nottingham, United Kingdom

  • Lister Hospital

    Stevenage, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust

    Cambridge, Cambridgeshire, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.